The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Rare Genetic Disorders, Quality of Life, Functional Impairment. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Examination of Families' Psychological Status and Quality of Life According to the Functional Independence Status of Children With Rare Genetic Diseases in Early Childhood
Overview
This study aims to examine the psychological status and quality of life of families with children who have rare genetic disorders. The focus of the study is to understand how the child's level of functional independence relates to the well-being of the family. Functional independence will be assessed using standardized tools, and parental psychological status and quality of life will be evaluated with validated questionnaires. The information gathered from this study may help improve the understanding of how rare genetic disorders affect family dynamics and daily functioning. The results may guide health care professionals in planning family-centered physiotherapy, psychological support, and care programs.
Detailed description
This observational, descriptive, and cross-sectional study aims to examine the associations between the functional independence levels of young children diagnosed with rare genetic disorders and various psychosocial outcomes of their caregivers, including depression, family functioning, sleep quality, and overall quality of life. Rare genetic disorders often begin in early childhood, require long-term medical follow-up and rehabilitation, and may negatively affect both the daily routines and psychosocial well-being of families. In this context, understanding family-centered physiotherapy and its role as a protective factor is crucial for strengthening family systems and supporting rehabilitation success.
The study population consists of caregivers of children aged 0-4 years with rare genetic diagnoses who are receiving physiotherapy at a rehabilitation center in Istanbul. A sample size of 45 participants was calculated based on Cohen's effect size approach, assuming a medium effect size (d = 0.5).
Functional independence of the child will be assessed using the Pediatric Functional Independence Measure (WeeFIM). Based on WeeFIM scores, parents will be categorized into two groups according to the child's functional level. Caregiver depression levels will be assessed using the Beck Depression Inventory; family functioning will be evaluated with the Family Functionality in Rehabilitation Scale; family impact will be measured with the Family Impact Scale; sleep quality will be evaluated using the Pittsburgh Sleep Quality Index; and quality of life will be assessed using the Nottingham Health Profile. Demographic information and details of physiotherapy participation will also be collected.
Data collection will begin after ethical approval and will last approximately three months. Following informed consent, all participants will complete the questionnaires in Turkish. The findings of this study are expected to provide a comprehensive understanding of the multidimensional challenges faced by families of children with rare genetic disorders and may guide the development of family-centered physiotherapy, psychosocial interventions, and supportive care programs.
Primary outcome measures
- Functional Independence Level of the Child (WeeFIM) [Time frame: At baseline (study enrollment)]
Secondary outcome measures (5)
- Beck Depression Inventory (BDI) [Time frame: At baseline (study enrollment)]
- Family Functionality in Rehabilitation [Time frame: At baseline (study enrollment)]
- Family Impact (Family Impact Scale) [Time frame: At baseline (study enrollment)]
- Sleep Quality (Pittsburgh Sleep Quality Index - PSQI) [Time frame: At baseline (study enrollment)]
- Quality of Life (Nottingham Health Profile - NHP) [Time frame: At baseline (study enrollment)]
Eligibility criteria
Inclusion criteria
- Caregivers of children aged 0-4 years diagnosed with a rare genetic disorder.
- The child must have been receiving physiotherapy for at least 6 months.
- Caregivers who voluntarily agree to participate and provide informed consent.
- Caregivers who are able to read and understand Turkish to complete the questionnaires.
Exclusion criteria
- Caregivers who have cognitive or language limitations that prevent them from completing the questionnaires.
- Caregivers who decline participation or submit incomplete questionnaire forms.
- Children or caregivers with an additional medical or neurological condition that prevents participation in the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
Turkey (Türkiye) · 1 center
- Bahcesehir University — Istanbul
Identifiers
NCT: NCT07348926 · BAU-FTR-YE-01